US Patent Issued to Geneseq on Sept. 9 for "Method of diagnosis, staging and monitoring of melanoma using microRNA gene expression" (Australian Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,481, issued on Sept. 9, was assigned to Geneseq Pty Ltd. (Melbourne, Australia).

"Method of diagnosis, staging and monitoring of melanoma using microRNA gene expression" was invented by Ryan Van Laar (Melbourne, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of diagnosing melanoma in a subject, the method comprising detecting microRNA expression levels. The present invention also relates to methods of assessing the disease stage of melanoma and/or monitoring said melanoma stage. Also, the present invention relates to selecting a treatment or modifying a treatment based on the diagnosis or stage of ...